Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27,767,902
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
9,666,018
-
Shares change
-
+1,228,016
-
Total reported value, excl. options
-
$416,088,660
-
Value change
-
+$53,128,968
-
Put/Call ratio
-
128%
-
Number of buys
-
71
-
Number of sells
-
-31
-
Price
-
$43.07
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q2 2014
108 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q2 2014.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9,666,018 shares
of 27,767,902 outstanding shares and own 35% of the company stock.
Largest 10 shareholders include FMR LLC (2,003,208 shares), Consonance Capital Management LP (1,546,097 shares), RA CAPITAL MANAGEMENT, LLC (1,539,586 shares), EAGLE ASSET MANAGEMENT INC (802,359 shares), SENZAR ASSET MANAGEMENT, LLC (255,128 shares), BlackRock Fund Advisors (254,706 shares), WALL STREET ASSOCIATES (219,200 shares), GLENMEDE TRUST CO NA (187,520 shares), VANGUARD GROUP INC (179,910 shares), and INSIGHT CAPITAL RESEARCH & MANAGEMENT INC (158,315 shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.